Assessment of Biotin Interference in Thyroid Function Tests

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2020 Mar 3

PMID 32118725

Citations 5

Authors

Youjia Zhang

Renjie Wang

Ying Dong

Guanning Huang

Bin Ji

Qing Wang

Affiliations

Soon will be listed here.

Abstract

The aim of the study was to systematically characterize the interference of biotin on thyroid function tests and biotin washout periods.Ten healthy adults were recruited with administration of 5 and 10 mg/d biotin for 7 days. Analyte concentrations of thyroid function tests were measured at baseline prior to starting biotin and from 2 hours to 2 days after withdrawal of 5 and 10 mg/d biotin. The outcomes were compared the baseline with the several points after taking biotin at Roche cobas e602, Beckman UniCel DxI 800, and Abbott Architect 2000 immunoassay platforms, respectively.Ingesting 5 or 10 mg/d of biotin for 7 days could produce positive or negative interference among the thyroid function tests at Roche cobas e602 and Beckman UniCel DxI 800 systems, but no interference on Abbott Architect 2000. Interference duration of 5 mg/d biotin for Roche cobas e602 and Beckman UniCel DxI 800 of thyroid function tests lasted for 8 hours, while 10 mg/d biotin interfered with Roche cobas e602 or Beckman UniCel DxI 800 for 1 day or 2 days.This study provides valuable guidance on biotin washout periods at doses common in over-the-counter supplements necessary to avoid false assay results.Trial registration: ChiCTR1800020472.

Citing Articles

The clinical significance of low dose biotin supplements (<300μg/day) in the treatment of patients with hypothyroidism: crucial or overestimated?.

Angelopoulos N, Paparodis R, Androulakis I, Anagnostis P, Boniakos A, Duntas L Thyroid Res. 2023; 16(1):18.

PMID: 37455308 PMC: 10351174. DOI: 10.1186/s13044-023-00162-8.

Biotin induced biochemical hyperthyroidism: a case report and review of the literature.

James A, Stalan J, Kuzhively J J Med Case Rep. 2023; 17(1):266.

PMID: 37370185 PMC: 10304644. DOI: 10.1186/s13256-023-04002-z.

Changes in Reported Dietary Supplement Use in Cognitively Normal National Alzheimer's Coordinating Center Participants Aged 55 and Older From 2015 to 2019.

Sandoval K J Nutr. 2023; 153(6):1771-1782.

PMID: 37044210 PMC: 10447883. DOI: 10.1016/j.tjnut.2023.04.004.

Hormone Immunoassay Interference: A 2021 Update.

Ghazal K, Brabant S, Prie D, Piketty M Ann Lab Med. 2021; 42(1):3-23.

PMID: 34374345 PMC: 8368230. DOI: 10.3343/alm.2022.42.1.3.

Biotin Interference in Assays for Thyroid Hormones, Thyrotropin and Thyroglobulin.

Ylli D, Soldin S, Stolze B, Wei B, Nigussie G, Nguyen H Thyroid. 2021; 31(8):1160-1170.

PMID: 34042535 PMC: 8420951. DOI: 10.1089/thy.2020.0866.

References

Samarasinghe S, Meah F, Singh V, Basit A, Emanuele N, Emanuele M . BIOTIN INTERFERENCE WITH ROUTINE CLINICAL IMMUNOASSAYS: UNDERSTAND THE CAUSES AND MITIGATE THE RISKS. Endocr Pract. 2017; 23(8):989-998. DOI: 10.4158/EP171761.RA. View

Zempleni J, Wijeratne S, Hassan Y . Biotin. Biofactors. 2009; 35(1):36-46. PMC: 4757853. DOI: 10.1002/biof.8. View

de Roeck Y, Philipse E, Twickler T, Van Gaal L . Misdiagnosis of Graves' hyperthyroidism due to therapeutic biotin intervention. Acta Clin Belg. 2017; 73(5):372-376. DOI: 10.1080/17843286.2017.1396676. View

Trambas C, Lu Z, Yen T, Sikaris K . Characterization of the scope and magnitude of biotin interference in susceptible Roche Elecsys competitive and sandwich immunoassays. Ann Clin Biochem. 2017; 55(2):205-215. DOI: 10.1177/0004563217701777. View

Wolf B . Clinical issues and frequent questions about biotinidase deficiency. Mol Genet Metab. 2010; 100(1):6-13. DOI: 10.1016/j.ymgme.2010.01.003. View

Kummer S, Hermsen D, Distelmaier F . Biotin Treatment Mimicking Graves' Disease. N Engl J Med. 2016; 375(7):704-6. DOI: 10.1056/NEJMc1602096. View

Piketty M, Polak M, Flechtner I, Gonzales-Briceno L, Souberbielle J . False biochemical diagnosis of hyperthyroidism in streptavidin-biotin-based immunoassays: the problem of biotin intake and related interferences. Clin Chem Lab Med. 2016; 55(6):780-788. DOI: 10.1515/cclm-2016-0606. View

Ardabilygazir A, Afshariyamchlou S, Mir D, Sachmechi I . Effect of High-dose Biotin on Thyroid Function Tests: Case Report and Literature Review. Cureus. 2018; 10(6):e2845. PMC: 6103391. DOI: 10.7759/cureus.2845. View

Lim S, Pilon A, Guechot J . Biotin interferes with free thyroid hormone and thyroglobulin, but not TSH measurements using Beckman-Access immunoassays. Ann Endocrinol (Paris). 2017; 78(3):186-187. DOI: 10.1016/j.ando.2016.08.001. View

10.

Wijeratne N, Doery J, Lu Z . Positive and negative interference in immunoassays following biotin ingestion: a pharmacokinetic study. Pathology. 2012; 44(7):674-5. DOI: 10.1097/PAT.0b013e32835a3c17. View

11.

Said H . Biotin: biochemical, physiological and clinical aspects. Subcell Biochem. 2011; 56:1-19. DOI: 10.1007/978-94-007-2199-9_1. View

12.

Barbesino G . Misdiagnosis of Graves' Disease with Apparent Severe Hyperthyroidism in a Patient Taking Biotin Megadoses. Thyroid. 2016; 26(6):860-3. DOI: 10.1089/thy.2015.0664. View

13.

Minkovsky A, Lee M, Dowlatshahi M, Angell T, Mahrokhian L, Petrides A . HIGH-DOSE BIOTIN TREATMENT FOR SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS MAY INTERFERE WITH THYROID ASSAYS. AACE Clin Case Rep. 2016; 2(4):e370-e373. PMC: 5134919. DOI: 10.4158/EP161261.CR. View

14.

Sedel F, Papeix C, Bellanger A, Touitou V, Lebrun-Frenay C, Galanaud D . High doses of biotin in chronic progressive multiple sclerosis: a pilot study. Mult Scler Relat Disord. 2015; 4(2):159-69. DOI: 10.1016/j.msard.2015.01.005. View

15.

Li D, Radulescu A, Shrestha R, Root M, Karger A, Killeen A . Association of Biotin Ingestion With Performance of Hormone and Nonhormone Assays in Healthy Adults. JAMA. 2017; 318(12):1150-1160. PMC: 5818818. DOI: 10.1001/jama.2017.13705. View

16.

Elston M, Sehgal S, du Toit S, Yarndley T, Conaglen J . Factitious Graves' Disease Due to Biotin Immunoassay Interference-A Case and Review of the Literature. J Clin Endocrinol Metab. 2016; 101(9):3251-5. DOI: 10.1210/jc.2016-1971. View

17.

Clerico A, Plebani M . Biotin interference on immunoassay methods: sporadic cases or hidden epidemic?. Clin Chem Lab Med. 2017; 55(6):777-779. DOI: 10.1515/cclm-2017-0070. View

18.

Lipner S . Rethinking biotin therapy for hair, nail, and skin disorders. J Am Acad Dermatol. 2018; 78(6):1236-1238. DOI: 10.1016/j.jaad.2018.02.018. View

19.

Batista M, Ferreira C, Faulhaber A, Hidal J, Lottenberg S, Mangueira C . Biotin interference in immunoassays mimicking subclinical Graves' disease and hyperestrogenism: a case series. Clin Chem Lab Med. 2016; 55(6):e99-e103. DOI: 10.1515/cclm-2016-0628. View

20.

Trambas C, Sikaris K, Lu Z . More on Biotin Treatment Mimicking Graves' Disease. N Engl J Med. 2016; 375(17):1698. DOI: 10.1056/NEJMc1611875. View